Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Wei Tong, PhD |
Innovation Grants |
2019 |
Pennsylvania |
Practical, Reproducible, and Statistically-Rigorous Workflows for Single-Nucleus Analysis of Childhood Cancer Data |
Johns Hopkins Bloomberg School of Public Health / Stephanie C. Hicks, PhD |
Crazy 8 Pilots |
2019 |
Maryland |
The anti-tumor immune microenvironment in the Sonic Hedgehog subclass of medulloblastoma |
Emory University / Anna Kenney, PhD |
Innovation Grants |
2019 |
Georgia |
Platform development for target identification in high risk pediatric leukemias |
Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD |
Crazy 8 Pilots |
2019 |
New York |
Targeting microenvironment-induced TGFB signaling to overcome drug resistance in acute lymphoblastic leukemia |
St. Jude Children’s Research Hospital / Charles Mullighan, MD |
Innovation Grants |
2019 |
Tennessee |
Saturating CRISPR gene body scans in MLL-rearranged leukemia |
Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD |
Innovation Grants |
2019 |
California |
Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy |
Dana-Farber Cancer Institute / Jun Qi, PhD |
Innovation Grants |
2019 |
Massachusetts |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Identifying targeted treatments for DICER1-associated sarcomas |
Research Institute of the McGill University Health Centre / William Foulkes, MD/PhD & Sidong Huang, PhD |
Innovation Grants |
2019 |
Quebec |
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD |
Reach Grants |
2019 |
Ohio |